April, 2025, Eutropics Protein/Protein interaction detectors platform is published in “Cancers” DOI: 10.3390/cancers17111852. In this We describe a new diagnostics platform based on a novel panel of antibody-based reagents that have significant research utility and potential clinical utility for the prediction of drug treatment responses or in diagnosing mechanisms underlying treatment resistance in both solid and blood cancers. There is a well-established scientific hypothesis regarding the significance of mitochondrial priming as a functional predictor of cancer cell response to drug-induced apoptosis signaling presented.
